Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholders??? Deficit (Unaudited)

v3.21.2
Condensed Consolidated Statements of Changes in Shareholders’ Deficit (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Noncontrolling Interest
Total
Balance at Dec. 31, 2019 $ 116,750 $ 37,266,328 $ (40,000,015) $ (2,616,937)
Balance (in Shares) at Dec. 31, 2019 116,749,633        
Shares issued for conversion of accounts payable $ 151 5,907 6,058
Shares issued for conversion of accounts payable (in Shares) 151,456        
Common shares issued for cash $ 7,000 273,000 280,000
Common shares issued for cash (in Shares) 7,000,000        
Common shares issued for conversion of accrued interest $ 475 12,245 12,720
Common shares issued for conversion of accrued interest (in Shares) 475,000        
Common shares issued for services $ 1,250 48,750 50,000
Common shares issued for services (in Shares) 1,250,000        
Issuance of warrants in connection with convertible debt 8,676 8,676
Accretion of stock-based compensation 170,072 170,072
Accretion of stock option expense 191,308 191,308
Net income (loss) (1,508,288) (1,508,288)
Balance at Mar. 31, 2020 $ 125,626 37,976,286 (41,508,303) (3,406,391)
Balance (in Shares) at Mar. 31, 2020 125,626,089        
Shares issued for conversion of accrued compensation $ 203 16,047 16,250
Shares issued for conversion of accrued compensation (in Shares) 203,125        
Common shares issued for conversion of debt, accrued interest and fees $ 12,800 78,565 91,365
Common shares issued for conversion of debt, accrued interest and fees (in Shares) 12,800,000        
Extinguishment loss related to conversion of debt 123,455 123,455
Common shares issued for conversion of Series A preferred shares and dividends $ 9,983 152,809 162,792
Common shares issued for conversion of Series A preferred shares and dividends (in Shares) 9,982,616        
Reclassification of put premium to equity upon conversion of Series A preferred 37,438 37,438
Common shares issued for cash $ 7,000 154,000 161,000
Common shares issued for cash (in Shares) 7,000,000        
Common shares issued for services $ 7,450 (7,450)
Common shares issued for services (in Shares) 7,450,000        
Issuance of warrants in connection with convertible debt 5,822 5,822
Accretion of stock-based compensation 117,515 117,515
Accretion of stock option expense 191,307 191,307
Accretion of stock-based professional fees 5,000 5,000
Net income (loss) (1,591,860) (1,591,860)
Balance at Jun. 30, 2020 $ 163,062 38,850,794 (43,100,163) (4,086,307)
Balance (in Shares) at Jun. 30, 2020 163,061,830        
Common shares issued for conversion of debt, accrued interest and fees $ 23,897 63,047 86,944
Common shares issued for conversion of debt, accrued interest and fees (in Shares) 23,896,800        
Extinguishment loss related to conversion of debt 174,464 174,464
Common shares issued for conversion of Series A preferred shares and dividends $ 6,150 46,482 52,632
Common shares issued for conversion of Series A preferred shares and dividends (in Shares) 6,150,085        
Reclassification of put premium to equity upon conversion of Series A preferred 12,105 12,105
Common shares issued for cash $ 21,538 258,462 280,000
Common shares issued for cash (in Shares) 21,538,462        
Common shares issued for services $ 500 6,000 6,500
Common shares issued for services (in Shares) 500,000        
Accretion of stock-based compensation 79,238 79,238
Accretion of stock option expense 193,410 193,410
Accretion of stock-based professional fees 5,000 5,000
Preferred stock dividends (2,795) (2,795)
Net income (loss) 480,396 480,396
Balance at Sep. 30, 2020 $ 215,147 39,689,002 (42,622,562) (2,718,413)
Balance (in Shares) at Sep. 30, 2020 215,147,177        
Balance at Dec. 31, 2020 $ 228,347 42,573,272 (45,968,839) (3,167,220)
Balance (in Shares) at Dec. 31, 2020 228,346,974        
Common shares issued for stock-based compensation $ 2,700 (2,700)
Common shares issued for stock-based compensation (in Shares) 2,700,000        
Beneficial conversion charge for issuance of Series B preferred shares for accrued compensation recorded as stock-based compensation 3,778,810 3,778,810
Common shares issued for accrued compensation $ 945 54,796 55,741
Common shares issued for accrued compensation (in Shares) 944,767        
Accretion of stock-based compensation 108,554 108,554
Accretion of stock-based professional fees 5,000 5,000
Common shares issued for professional fees $ 1,550 112,550 114,100
Common shares issued for professional fees (in Shares) 1,550,000        
Common shares issued for cashless warrant exercise $ 1,008 (1,008)  
Common shares issued for cashless warrant exercise (in Shares) 1,008,000        
Preferred stock dividends and deemed dividend 2,845,238 (2,855,576) (10,338)
Net income (loss) (4,863,973) (4,863,973)
Balance at Mar. 31, 2021 $ 234,550 49,474,512 (53,688,388) (3,979,326)
Balance (in Shares) at Mar. 31, 2021 234,549,741        
Balance at Dec. 31, 2020 $ 228,347 42,573,272 (45,968,839) (3,167,220)
Balance (in Shares) at Dec. 31, 2020 228,346,974        
Common shares issued for cash         347,142
Balance at Sep. 30, 2021 $ 274,049 52,130,242 (56,325,555) 70,182 (3,851,082)
Balance (in Shares) at Sep. 30, 2021 274,048,481        
Balance at Mar. 31, 2021 $ 234,550 49,474,512 (53,688,388) (3,979,326)
Balance (in Shares) at Mar. 31, 2021 234,549,741        
Accretion of stock-based compensation 51,192 51,192
Common shares issued for professional fees $ 2,700 138,300 141,000
Common shares issued for professional fees (in Shares) 2,700,000        
Common shares issued for accounts payable $ 3,801 114,037 117,838
Common shares issued for accounts payable (in Shares) 3,801,224        
Preferred stock dividends and deemed dividend   (11,478) (11,478)
Net income (loss) (579,025) (579,025)
Balance at Jun. 30, 2021 $ 241,051 49,778,041 (54,278,891) (4,259,799)
Balance (in Shares) at Jun. 30, 2021 241,050,965        
Accretion of stock-based compensation 64,842     64,842
Common shares issued for professional fees $ 3,000 88,500 91,500
Common shares issued for professional fees (in Shares) 3,000,000        
Common shares issued for compensation $ 1,977 22,436 24,413
Common shares issued for compensation (in Shares) 1,976,500        
Common shares issued for acquisition $ 28,021 666,900 694,921
Common shares issued for acquisition (in Shares) 28,021,016        
Initial noncontrolling in acquired business 36,031 36,031
Preferred stock dividends and deemed dividend   1,509,523 (1,521,736) (12,213)
Net income (loss) (524,928) 34,151 (490,777)
Balance at Sep. 30, 2021 $ 274,049 $ 52,130,242 $ (56,325,555) $ 70,182 $ (3,851,082)
Balance (in Shares) at Sep. 30, 2021 274,048,481